AMRN: Oppenheimer downgrades at $7 LOL they are full of it. I might take advantage of this manipulation and get in today. On other note, GILD added Vascepa to NASH trial
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.